Observational studyArchives of gynecology and obstetrics2018
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
Observational study in Archives of gynecology and obstetrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.
- Intravenous iron versus blood transfusion for postpartum anemia: a systematic review and meta-analysis.Systematic reviews · 2024Pooled it
- Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis.The Indian journal of medical research · 2024Pooled it
- Pooled it
- Testing equivalence of two doses of intravenous iron to treat iron deficiency in pregnancy: A randomised controlled trial.BJOG : an international journal of obstetrics and gynaecology · 2023Trial
- Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.BMC pregnancy and childbirth · 2019Trial
- Review
- Prescribing and dosing patterns of ferric carboxymaltose for iron deficiency anemia: a real-world study from Saudi Arabia.Frontiers in medicine · 2026Article
- Article
- Review
- Observational
- Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement.Internal medicine journal · 2025Article
- Ferric carboxymaltose: A game changer in the management of iron deficiency anaemia in pregnancy.Journal of family medicine and primary care · 2024Article
- A new effect of intravenous iron treatment in pregnancy: contraction in nonstress test and timing of labor.Revista da Associacao Medica Brasileira (1992) · 2024Article
- Approaches to Address the Anemia Challenge.The Journal of nutrition · 2023Article
- Patient blood management to minimize transfusions during the postpartum period.Obstetrics & gynecology science · 2023Article
- Efficacy of ferric carboxy maltose in treatment of iron deficiency/iron deficiency anaemia during pregnancy.Przeglad menopauzalny = Menopause review · 2023Article
- Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding.Przeglad menopauzalny = Menopause review · 2022Article
- The incidence, complications, and treatment of iron deficiency in pregnancy.European journal of haematology · 2022Review
- A Randomised Controlled Trial to Compare Injection Ferric Carboxymaltose and Oral Iron in Treating Iron Deficiency Anemia During Pregnancy.Journal of obstetrics and gynaecology of India · 2022Article
- High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.Drug safety · 2022Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the efficacy and safety of intravenous ferric carboxymaltose administration to pregnant women with varying severities of iron deficiency anemia and iron deficiency without anemia.
methodsIn this prospective observational study of local obstetric practice, we analyzed data from 863 pregnant women with iron deficiency according to anemia status and severity. All women were treated with intravenous ferric carboxymaltose in pregnancy. Treatment efficacy was assessed by repeat hemoglobin measurements at 3 and 6 week post-infusion and ferritin levels, where available. Safety was assessed by analysis of adverse events, fetal heart rate monitoring, and newborn health outcome data.
resultsFerric carboxymaltose significantly increased hemoglobin in women with mild, moderate, and severe iron deficiency anemia and women with iron deficiency alone at 3 and 6 week post-infusion (p < 0.01 for all). No hemoconcentration occurred in iron-deficient women without anemia. No serious adverse events were recorded, with minor temporary side effects (including local skin irritation, nausea, and headache) occurring in 96 (11%) women. No adverse fetal or neonatal outcomes were observed.
conclusionsFerric carboxymaltose infusion corrects iron deficiency or various degrees of iron deficiency anemia efficaciously and safely pregnant women, and does not cause hemoconcentration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.